Celldex Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Celldex Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Celldex Therapeutics Inc.
Rating: 1.61883325
Author: Trendlyne DVM scores

about

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products ta...

23.87 1.51 (6.75%)

49.21% Fall from 52W High

1.2M

XNAS Volume

XNAS 23 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

7.8 / 100

Technically Neutral

56.9 / 100

1Yr Price target upside is 145%

13 analysts

Celldex Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Celldex Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products ta...

49.21% Fall from 52W High

SWOT Analysis

Celldex Therapeutics Inc. Live Price Chart